Clinical Trial Update: Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]

View source ↗

Summary

A Phase 4 safety study comparing olanzapine to a comparator in schizophrenia and schizoaffective disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2009-07-23